BIT BIO
LIVE

Serial Number

79293679

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

May 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIT BIO Trademark

Serial Number: 79293679 • Registration: 6413683

BIT BIO is a trademark filed by Bit Bio Limited on May 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

May 6, 2020

Registration Date

July 13, 2021

Published for Opposition

April 27, 2021

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not live

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific laboratory, research, and consulting services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation scientific technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services; Consultancy relating to biotechnology; Scientific and technological consultancy relating to drug screening; Scientific and technological consultancy relating to genetic screening; Scientific and technological consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical, therapeutic or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Biological preparations for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for drug screening for medical, therapeutic or clinical use; Cell preparations for genetic testing, screening for medical, therapeutic or clinical purposes; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical purposes; Cell separation reagents for medical, therapeutic or clinical purposes; Dietary supplements; Protein supplements; nutrition supplements

Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media, for scientific or research use other than for medical or veterinary use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells other than for medical use; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology other than for medical use; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical research use; Cell preparations for drug screening for research use; Genetically or otherwise modified cells for research use; Cells which are propagated, cultivated and expanded in bioreactors for research use

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 17, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 13, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 25, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 7, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2021 CNEA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 2, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 22, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Sep 22, 2020 MAFR
NON-FINAL ACTION WRITTEN
Sep 21, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR